Non-Invasive Prenatal Testing Market Size 2025, Growth Outlook, Market Dynamics, Competitive Landscape and Industry Research Insights

QY Research has recently published a research report titled, "Global Non-Invasive Prenatal Testing Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Non-Invasive Prenatal Testing market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for any challenges ahead in time. It provides regional analysis of the global Non-Invasive Prenatal Testing market to unveil key opportunities available in different parts of the world. The competitive landscape is broadly assessed along with company profiling of leading players operating in the global Non-Invasive Prenatal Testing market. The report provides detailed statistics and accurate market figures, viz. market share, CAGR, gross margin, and those related to revenue, production, consumption, and sales.

The global market for Non-Invasive Prenatal Testing was estimated to be worth US$ 5999 million in 2024 and is forecast to a readjusted size of US$ 12087 million by 2031 with a CAGR of 10.7% during the forecast period 2025-2031.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.qyresearch.in/request-sample/medical-care-non-invasive-prenatal-testing-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The report has been compiled with the use of latest primary and secondary research methodologies. Our sources are reliable and trustworthy - so you don't have to worry about the authenticity and accuracy of this research study. We have made use of qualitative and quantitative analysis to present to you an all-inclusive, all-encompassing research study on the global Non-Invasive Prenatal Testing market. The report also includes SWOT analysis, PESTLE analysis, and Porter's Five Forces Model analysis to offer you a complete and comprehensive study on crucial aspects of the global Non-Invasive Prenatal Testing market.

The Non-Invasive Prenatal Testing market has developed rapidly in recent years, driven by increasing awareness of prenatal care, advancements in next-generation sequencing (NGS) technology, and a growing demand for safer, more accurate genetic screening methods. The test is widely adopted in many developed countries and is gradually becoming more accessible in emerging markets due to decreasing costs and improving healthcare infrastructure. NIPT has shifted from being a high-end diagnostic tool to a routine option in prenatal screening, especially among high-risk pregnancies. As healthcare systems continue to emphasize early disease detection and prevention, NIPT is increasingly integrated into standard prenatal care protocols.

The competitive landscape is shaped by biotechnology firms and diagnostic service providers who invest in improving testing accuracy, expanding detectable conditions, and reducing turnaround time. Moreover, strategic partnerships between hospitals and genetic testing companies have enhanced service availability and promoted patient education. While regulatory differences exist between regions, the global trend leans toward the inclusion of NIPT in public health systems and insurance coverage. Continuous innovation, coupled with supportive policies, is expected to drive further adoption and market expansion.

Key Players Mentioned in the Global Non-Invasive Prenatal Testing Market Research Report:

Labcorp Holdings
Roche
Natera
Genomic Diagnostics
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics

Market Segments

Our market analysts are experts in deeply segmenting the global Non-Invasive Prenatal Testing market and thoroughly evaluating the growth potential of each and every segment studied in the report. Right at the beginning of the research study, the segments are compared on the basis of consumption and growth rate for a review period of nine years. The segmentation study included in the report offers a brilliant analysis of the global Non-Invasive Prenatal Testing market, taking into consideration the market potential of different segments studied. It assists market participants to focus on high-growth areas of the global Non-Invasive Prenatal Testing market and plan powerful business tactics to secure a position of strength in the industry.

Details of Non-Invasive Prenatal Testing Market Segmentation: -

Segment by Type:

Consumables & Reagents
Instruments

Segment by Application:

0-12 Weeks
13-24 Weeks
25-36 Weeks

All of the segments studied in the research study are analyzed on the basis of BPS, market share, revenue, and other important factors. Our research study shows how different segments are contributing to the growth of the global Non-Invasive Prenatal Testing market. It also provides information on key trends related to the segments included in the report. This helps market players to concentrate on high-growth areas of the global Non-Invasive Prenatal Testing market. The research study also offers separate analysis on the segments on the basis of absolute dollar opportunity.

Segment by Region

North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

How can the research study help your business?

(1) The information presented in the Non-Invasive Prenatal Testing report helps your decision makers to become prudent and make the best business choices.

(2) The report enables you to see the future of the global Non-Invasive Prenatal Testing market and accordingly take decisions that will be in the best interest of your business.

(3) It offers you a forward-looking perspective of the global Non-Invasive Prenatal Testing market drivers and how you can secure significant market gains in the near future.

(4) It provides SWOT analysis of the global Non-Invasive Prenatal Testing market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.

(5) It also assesses the changing competitive dynamics of the global Non-Invasive Prenatal Testing market using pin-point evaluation.

Request Pre-Order Enquiry or Customized Research on This Report: https://www.qyresearch.in/pre-order-inquiry/medical-care-non-invasive-prenatal-testing-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Table of Contents

1 Market Overview
1.1 Non-Invasive Prenatal Testing Product Introduction
1.2 Global Non-Invasive Prenatal Testing Market Size Forecast (2020-2031)
1.3 Non-Invasive Prenatal Testing Market Trends & Drivers
1.3.1 Non-Invasive Prenatal Testing Industry Trends
1.3.2 Non-Invasive Prenatal Testing Market Drivers & Opportunity
1.3.3 Non-Invasive Prenatal Testing Market Challenges
1.3.4 Non-Invasive Prenatal Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-Invasive Prenatal Testing Players Revenue Ranking (2024)
2.2 Global Non-Invasive Prenatal Testing Revenue by Company (2020-2025)
2.3 Key Companies Non-Invasive Prenatal Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Non-Invasive Prenatal Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Non-Invasive Prenatal Testing
2.6 Non-Invasive Prenatal Testing Market Competitive Analysis
2.6.1 Non-Invasive Prenatal Testing Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Non-Invasive Prenatal Testing Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Consumables & Reagents
3.1.2 Instruments
3.2 Global Non-Invasive Prenatal Testing Sales Value by Type
3.2.1 Global Non-Invasive Prenatal Testing Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Type (2020-2031)
3.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Type (%) (2020-2031)
4 Segmentation by Method
4.1 Introduction by Method
4.1.1 Ultrasound Detection
4.1.2 Biochemical Screening Tests
4.1.3 Cell-free DNA in Maternal Plasma Tests
4.2 Global Non-Invasive Prenatal Testing Sales Value by Method
4.2.1 Global Non-Invasive Prenatal Testing Sales Value by Method (2020 VS 2024 VS 2031)
4.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Method (2020-2031)
4.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Method (%) (2020-2031)
5 Segmentation by End-use
5.1 Introduction by End-use
5.1.1 Hospitals & Clinics
5.1.2 Diagnostic Laboratories
5.2 Global Non-Invasive Prenatal Testing Sales Value by End-use
5.2.1 Global Non-Invasive Prenatal Testing Sales Value by End-use (2020 VS 2024 VS 2031)
5.2.2 Global Non-Invasive Prenatal Testing Sales Value, by End-use (2020-2031)
5.2.3 Global Non-Invasive Prenatal Testing Sales Value, by End-use (%) (2020-2031)
6 Segmentation by Application
6.1 Introduction by Application
6.1.1 0-12 Weeks
6.1.2 13-24 Weeks
6.1.3 25-36 Weeks
6.2 Global Non-Invasive Prenatal Testing Sales Value by Application
6.2.1 Global Non-Invasive Prenatal Testing Sales Value by Application (2020 VS 2024 VS 2031)
6.2.2 Global Non-Invasive Prenatal Testing Sales Value, by Application (2020-2031)
6.2.3 Global Non-Invasive Prenatal Testing Sales Value, by Application (%) (2020-2031)
7 Segmentation by Region
7.1 Global Non-Invasive Prenatal Testing Sales Value by Region
7.1.1 Global Non-Invasive Prenatal Testing Sales Value by Region: 2020 VS 2024 VS 2031
7.1.2 Global Non-Invasive Prenatal Testing Sales Value by Region (2020-2025)
7.1.3 Global Non-Invasive Prenatal Testing Sales Value by Region (2026-2031)
7.1.4 Global Non-Invasive Prenatal Testing Sales Value by Region (%), (2020-2031)
7.2 North America
7.2.1 North America Non-Invasive Prenatal Testing Sales Value, 2020-2031
7.2.2 North America Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2031
7.3 Europe
7.3.1 Europe Non-Invasive Prenatal Testing Sales Value, 2020-2031
7.3.2 Europe Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2031
7.4 Asia Pacific
7.4.1 Asia Pacific Non-Invasive Prenatal Testing Sales Value, 2020-2031
7.4.2 Asia Pacific Non-Invasive Prenatal Testing Sales Value by Region (%), 2024 VS 2031
7.5 South America
7.5.1 South America Non-Invasive Prenatal Testing Sales Value, 2020-2031
7.5.2 South America Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2031
7.6 Middle East & Africa
7.6.1 Middle East & Africa Non-Invasive Prenatal Testing Sales Value, 2020-2031
7.6.2 Middle East & Africa Non-Invasive Prenatal Testing Sales Value by Country (%), 2024 VS 2031
8 Segmentation by Key Countries/Regions
8.1 Key Countries/Regions Non-Invasive Prenatal Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031
8.2 Key Countries/Regions Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.3 United States
8.3.1 United States Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.3.2 United States Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.3.3 United States Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
8.4 Europe
8.4.1 Europe Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.4.2 Europe Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.4.3 Europe Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
8.5 China
8.5.1 China Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.5.2 China Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.5.3 China Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
8.6 Japan
8.6.1 Japan Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.6.2 Japan Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.6.3 Japan Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.7.2 South Korea Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.7.3 South Korea Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.8.2 Southeast Asia Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.8.3 Southeast Asia Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
8.9 India
8.9.1 India Non-Invasive Prenatal Testing Sales Value, 2020-2031
8.9.2 India Non-Invasive Prenatal Testing Sales Value by Type (%), 2024 VS 2031
8.9.3 India Non-Invasive Prenatal Testing Sales Value by Application, 2024 VS 2031
9 Company Profiles
9.1 Labcorp Holdings
9.1.1 Labcorp Holdings Profile
9.1.2 Labcorp Holdings Main Business
9.1.3 Labcorp Holdings Non-Invasive Prenatal Testing Products, Services and Solutions
9.1.4 Labcorp Holdings Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.1.5 Labcorp Holdings Recent Developments
9.2 Roche
9.2.1 Roche Profile
9.2.2 Roche Main Business
9.2.3 Roche Non-Invasive Prenatal Testing Products, Services and Solutions
9.2.4 Roche Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.2.5 Roche Recent Developments
9.3 Natera
9.3.1 Natera Profile
9.3.2 Natera Main Business
9.3.3 Natera Non-Invasive Prenatal Testing Products, Services and Solutions
9.3.4 Natera Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.3.5 Natera Recent Developments
9.4 Genomic Diagnostics
9.4.1 Genomic Diagnostics Profile
9.4.2 Genomic Diagnostics Main Business
9.4.3 Genomic Diagnostics Non-Invasive Prenatal Testing Products, Services and Solutions
9.4.4 Genomic Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.4.5 Genomic Diagnostics Recent Developments
9.5 BGI Genomics
9.5.1 BGI Genomics Profile
9.5.2 BGI Genomics Main Business
9.5.3 BGI Genomics Non-Invasive Prenatal Testing Products, Services and Solutions
9.5.4 BGI Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.5.5 BGI Genomics Recent Developments
9.6 Quest Diagnostics
9.6.1 Quest Diagnostics Profile
9.6.2 Quest Diagnostics Main Business
9.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Products, Services and Solutions
9.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.6.5 Quest Diagnostics Recent Developments
9.7 Illumina
9.7.1 Illumina Profile
9.7.2 Illumina Main Business
9.7.3 Illumina Non-Invasive Prenatal Testing Products, Services and Solutions
9.7.4 Illumina Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.7.5 Illumina Recent Developments
9.8 Berry Genomics
9.8.1 Berry Genomics Profile
9.8.2 Berry Genomics Main Business
9.8.3 Berry Genomics Non-Invasive Prenatal Testing Products, Services and Solutions
9.8.4 Berry Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2020-2025)
9.8.5 Berry Genomics Recent Developments
10 Industry Chain Analysis
10.1 Non-Invasive Prenatal Testing Industrial Chain
10.2 Non-Invasive Prenatal Testing Upstream Analysis
10.2.1 Key Raw Materials
10.2.2 Raw Materials Key Suppliers
10.2.3 Manufacturing Cost Structure
10.3 Midstream Analysis
10.4 Downstream Analysis (Customers Analysis)
10.5 Sales Model and Sales Channels
10.5.1 Non-Invasive Prenatal Testing Sales Model
10.5.2 Sales Channel
10.5.3 Non-Invasive Prenatal Testing Distributors
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

Ankit Jain - Director, Global Digital Marketing

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Email- ankit@qyresearch.com

This release was published on openPR.